Form 8-K · Current report
Thermo Fisher Scientific 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0000097745
- Accession no.
- 0000097745-26-000173
Summary
Thermo Fisher Scientific reported third-quarter 2026 revenue of $12.14 billion, up 9% with 6% organic growth, alongside GAAP diluted EPS of $4.64 (up 9%) and adjusted EPS of $6.68 (up 15%), and said it would provide updated 2026 guidance on its earnings call. CEO Marc N. Casper attributed the quarter to the company's growth strategy and its PPI Business System.
Key points
- Third-quarter 2026 GAAP operating income was $2.26 billion at an 18.6% margin, versus 17.4% a year earlier, and adjusted operating margin was 24.5% versus 23.3%.
- Thermo Fisher completed its previously announced divestiture of its microbiology business during the quarter.
- The company launched the Thermo Scientific Orbitrap Isora mass spectrometer, the EMPAD G2 electron detector, the FDA-cleared EliA CTD 13 Screen, and the Ion 560 sequencing chip.
- With Mayo Clinic, Thermo Fisher launched Precure, an initiative combining data from more than one million patient samples with its proteomics technologies, and opened an AI-Automation Innovation Center in South Korea and a distribution center in Kentucky.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 21, 2026, the Registrant announced its financial results for the fiscal quarter ended September 26, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference. The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.